Cryoneurolysis for Spasticity Treatment: Long-term Clinical Outcomes and Mechanisms in the Central Nervous System
A legfontosabb adatok
- Hol
- London (Kanada)A helyszín megnézése
AI-kivonat: kiket keres a vizsgálat
A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.
A vizsgálat olyan felnőtteket keres, akiknek stroke után izomgörcsösségük (spaszticitás) van, és kaphatnak krioneurolízist, vagyis ideg-fagyasztásos kezelést. Azt vizsgálja, hogyan hat ez az agyra körülbelül hat hónapon át.
- Életkor
- 18 éves vagy idősebb
- Nem
- Nők és férfiak is részt vehetnek.
- A betegség stádiuma
- Stroke utáni izomgörcsösség (spaszticitás), a módosított Ashworth-skálán 2 vagy magasabb pontszámmal, és a felső végtagban legalább halvány mozgás.
- Korábbi kezelés
- Az elmúlt 3 hónapban nem kaphatott botulinum-A neurotoxint. Korábban nem kaphatott a vizsgálatban megcélzott idegen görcsösség miatti ideg-specifikus kezelést (fenolos neurolízis, rádiófrekvenciás abláció vagy krioneurolízis). Görcsoldó gyógyszer esetén annak adagolása a követés alatt stabil kell maradjon.
- Biomarker vagy leletérték
- A diagnosztikus idegblokád növelje a mozgásterjedelmet vagy csökkentse a görcsösséget, és ne okozzon nemkívánatos funkcióvesztést.
A részvétel fő kizáró okai
- TMS-re vonatkozó ellenjavallat (például korábbi epilepsziás roham vagy terhesség)
- 3T MRI-re vonatkozó ellenjavallat (például bizonyos fém implantátumok)
- Nem tud beleegyező nyilatkozatot adni (például súlyos kognitív károsodás miatt)
- Toxininjekció görcsösség miatt (botulinum-A toxin vagy azzal egyenértékű) a kiinduló vizsgálat előtti 3 hónapon belül vagy a követés alatt
- Nem érti és nem tudja követni az utasításokat angolul
Gépi kiolvasás: 2026. november 12.
Helyszínek itt: Kanada
- Parkwood InstituteLondon, KanadaContact: Nagina Naz, BScRésztvevőt keres
Kérdések a vizsgálat csapatának
- Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
- Megtérítik az utazási költséget?
- Megtarthatom a saját orvosomat?
- Mi történik, ha ki akarok lépni?
Contact the study team: see the registry record → Contacts and Locations
Oldal nyomtatása az orvosomnakA vizsgálat adatai
- Ki végzi
- Sue Peters
- Azonosító
- NCT06958289
- A regiszteradat frissítve
- 2026. április 21.
- Eredeti leírás
Spasticity can make regular daily activities difficult or impossible. Cryoneurolysis is a new technique to treat spasticity that is currently being tested. For this technique, a needle is inserted alongside a nerve implicated in spasticity. The needle then freezes and causes the nerve to break down. The nerve breaking down seems to provide relief for spasticity. The investigators are interested in testing the long-term effects of cryoneurolysis on the function of the brain over six months after treatment. The investigators are testing the brain's function using transcranial magnetic stimulation (TMS) which involves a magnet activating specific parts of the brain that cause muscles to fire; magnetic resonance imaging (MRI) which uses to examine brain structure; functional near-infrared spectroscopy (fNIRS) to examine brain function. The investigators believe that there will be a change in these measures that are related to the long-lasting effects of cryoneurolysis. Cryoneurolysis is not a part of standard care after stroke but is approved in Canada for patients. It has been used extensively in the past for treating pain. TMS is a way of studying how the brain sends signals to muscles to make movement. During these sessions, a researcher will use a magnet to turn on specific neurons in the brain that will cause muscles to contract. The investigators can study the way eyes and muscles respond to better understand how the brain is sending information about moving the body to the muscles. FNIRS is a new way of studying how the brain works. During these sessions, a researcher will fit the participant with a cap that has several lights on it. The light travels through hair, scalp, and skull where it interacts with blood in the brain. By studying the changes in the colour of the blood in the brain, researchers can understand which parts of the brain are active during specific tasks. Magnetic Resonance Imaging (MRI) involves a powerful magnet that takes very detailed pictures of the brain. These images help the investigators to understand how a stroke is related to spasticity. Also, these images are helpful to make the stimulation with TMS more accurate. Study participation will require five visits to the Parkwood Institute Main Building and one visit to St. Joseph's Hospital. The entire study will take place over roughly six months. The investigators are recruiting 25 people with stroke who are eligible for cryoneurolysis to participate in the study.A teljes eredeti leírásKevesebb
Cryoneurolysis for Spasticity Treatment: Quantifying Long-term Clinical Outcomes and Exploring Mechanisms Within the Central Nervous System
Spasticity can make regular daily activities difficult or impossible. Cryoneurolysis is a new technique to treat spasticity that is currently being tested. For this technique, a needle is inserted alongside a nerve implicated in spasticity. The needle then freezes and causes the nerve to break down. The nerve breaking down seems to provide relief for spasticity. The investigators are interested in testing the long-term effects of cryoneurolysis on the function of the brain over six months after treatment. The investigators are testing the brain's function using transcranial magnetic stimulation (TMS) which involves a magnet activating specific parts of the brain that cause muscles to fire; magnetic resonance imaging (MRI) which uses to examine brain structure; functional near-infrared spectroscopy (fNIRS) to examine brain function. The investigators believe that there will be a change in these measures that are related to the long-lasting effects of cryoneurolysis. Cryoneurolysis is not a part of standard care after stroke but is approved in Canada for patients. It has been used extensively in the past for treating pain. TMS is a way of studying how the brain sends signals to muscles to make movement. During these sessions, a researcher will use a magnet to turn on specific neurons in the brain that will cause muscles to contract. The investigators can study the way eyes and muscles respond to better understand how the brain is sending information about moving the body to the muscles. FNIRS is a new way of studying how the brain works. During these sessions, a researcher will fit the participant with a cap that has several lights on it. The light travels through hair, scalp, and skull where it interacts with blood in the brain. By studying the changes in the colour of the blood in the brain, researchers can understand which parts of the brain are active during specific tasks. Magnetic Resonance Imaging (MRI) involves a powerful magnet that takes very detailed pictures of the brain. These images help the investigators to understand how a stroke is related to spasticity. Also, these images are helpful to make the stimulation with TMS more accurate. Study participation will require five visits to the Parkwood Institute Main Building and one visit to St. Joseph's Hospital. The entire study will take place over roughly six months. The investigators are recruiting 25 people with stroke who are eligible for cryoneurolysis to participate in the study.
Bevonási feltételek: have increased range of motion or reduced spasticity with diagnostic nerve block,; have no undesired loss of function with a diagnostic nerve block,; score 2 or higher in the Modified Ashworth scale,; have at least flickers of movement in the upper extremity,; have not received botulinum-A neurotoxin within the past 3 months,; if on anti-spastic medication, maintaining anti-spastic medications on a stable schedule over the course of the follow up period, and; they can understand and follow instructions in English.
Kizáró feltételek: have contraindications to TMS (i.e., history of seizure, pregnancy) or 3T MRI (i.e., certain metallic implants),; are unable to provide informed consent (i.e., severe cognitive impairment),; receive any toxin injections for spasticity (Botulinum-A Toxin or equivalent) within 3 months of initial baseline assessments or at any time over the course of the follow-up period; Have previously undergone any nerve-specific interventions (phenol neurolysis, radio-frequency ablation, or cryoneurolysis) for spasticity on a nerve that will be targeted for this study.